RETROVIR
250MG CPS DUR 40
| SÚKL code | 0180429 |
|---|---|
| Name of the product | RETROVIR |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | RETROVIR |
| Supplement | 250MG CPS DUR 40 |
| Strenght | 250MG |
| Pharmaceutical form | Capsule, hard |
| Package | 40 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | ZIDOVUDINE (ZIDOVUDINUM) |
| ATC group | J05AF01 |
| ATC group name | ZIDOVUDIN |
Marketing authorisation information
| Registration Number | 42/ 151/88-C |
|---|---|
| Type of MA | National |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 05. 2019 |
| MA Holder | ViiV Healthcare UK Limited, Brentford |
| MA Holder country | VELKÁ BRITÁNIE |
| Actual MA holder | ViiV Healthcare BV, Amersfoort |
| Actual MA holder country | NIZOZEMSKO |
cz